Home › Funds › PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE › CDNA

PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE position in CDNA

CAREDX INC · Health Care

PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE reported holding 500,000 shares of CDNA (CAREDX INC) in its Q1 2026 13F filing — a position valued at US$8.7M, representing 11.80% of its reported portfolio and ranking #3 among its reported holdings. PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE has disclosed CDNA holdings in 5 of the last 5 reported quarters, going back to Q1 2025.

Latest position (Q1 2026)500.00K sh
Reported value held$8.68M
Portfolio Weight11.80%
First reportedQ1 2025
Last changeAdd
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's CDNA position evolved

PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE first disclosed a stake in CDNA in Q1 2025 at 50,000 shares (US$888K). The position peaked in Q1 2026 at 500,000 shares, worth US$8.7M. Across 5 filings, PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 500,000 shares valued at US$8.7M — an increase of 125,000 shares quarter over quarter.. Notable position changes include a 339% increase in Q2 2025 (shares fell 26% over the following quarter), a 94% increase in Q3 2025 (shares rose 30% over the following quarter), a 33% increase in Q1 2026 (shares rose 64% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 50.00K $887.50K New
Q2 2025 219.40K $4.29M Add
Q3 2025 425.00K $6.18M Add
Q4 2025 375.00K $7.07M Reduce
Q1 2026 500.00K $8.68M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About CDNA and 13F data

CDNA (CAREDX INC) is a Health Care company. 41 other funds we track also report a position in CDNA — the largest reported positions include DEERFIELD MANAGEMENT COMPANY, L.P. (US$56.9M), GAGNON SECURITIES LLC (US$50.5M), Ophir Asset Management Pty Ltd (US$36.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding CDNA

All CDNA fund holders →

FAQ

How long has PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE held CDNA?

PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE has disclosed CDNA holdings in 5 of the last 5 reported quarters, going back to Q1 2025.

What is PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE's current position in CDNA?

As of Q1 2026, PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE holds 500.00K shares of CDNA (CAREDX INC), valued at $8.68M, representing 11.80% of its reported portfolio and ranking #3.

Has PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE been buying or selling CDNA?

In the latest 13F filing (Q1 2026), PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE increased its position in CDNA. The position peaked in Q1 2026 at 500.00K shares.

Which other funds hold CDNA?

Other major institutional holders of CDNA include DEERFIELD MANAGEMENT COMPANY, L.P., GAGNON SECURITIES LLC, Ophir Asset Management Pty Ltd, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.